Overview
Postpartum hemorrhage remains one of the most urgent complications of childbirth and a major cause of maternal illness and death worldwide. When bleeding occurs after vaginal delivery, the first steps usually include uterine massage and medications that help the uterus contract, such as oxytocin and other uterotonics. If bleeding continues, clinicians may use intrauterine balloon tamponade, a device placed inside the uterus and filled with fluid to apply pressure from within and slow or stop the bleeding.
A key practical question has been how long the balloon needs to stay in place. In many hospitals, balloons are left for 12 to 24 hours, but that timing has largely been based on practice patterns rather than strong evidence. This randomized controlled trial asked a focused question: for postpartum hemorrhage caused by uterine atony after vaginal birth, is keeping the intrauterine balloon in place for 6 hours noninferior to keeping it in place for 18 hours?
The study found that 6 hours was noninferior to 18 hours for controlling blood loss. In other words, the shorter duration performed just as well within the study’s predefined safety margin. These findings suggest that, for appropriately selected and stable patients, balloon removal after 6 hours may be reasonable.
Why This Study Matters
Uterine atony, or poor contraction of the uterus after delivery, is the most common cause of postpartum hemorrhage. If first-line treatments do not work, intrauterine balloon tamponade can be lifesaving. However, leaving the balloon in place longer than necessary may increase patient discomfort, prolong monitoring, delay mobility, and potentially raise the burden of catheter-related care.
At the same time, removing the balloon too early could risk recurrent bleeding. That uncertainty has made duration decisions variable across hospitals and clinicians. This trial addresses a very practical issue that affects labor and delivery units every day: once bleeding has been controlled, do patients really need the balloon for most of a day, or is a shorter period enough?
The answer matters not only for patient comfort but also for resource use, nursing care, and clinical protocols. If shorter balloon duration is safe and effective, it could simplify postpartum management without compromising hemorrhage control.
How the Trial Was Designed
This was a pragmatic randomized noninferiority trial. A noninferiority design does not aim to prove that one treatment is better than another; instead, it tests whether a shorter or simpler approach is not meaningfully worse than the standard approach by more than a preset margin.
Participants were patients with postpartum hemorrhage due to uterine atony after vaginal delivery who required intrauterine balloon tamponade. They were randomly assigned in a 1:1 ratio to one of two groups:
1. Balloon left in place for 6 hours
2. Balloon left in place for 18 hours
Randomization was stratified by the amount of blood loss already present at the time the balloon was placed, which helps balance severity between groups. The main outcome was total quantitative blood loss from the time of balloon placement to 18 hours afterward. The trial planned to enroll 64 participants to determine whether the difference between groups stayed within the noninferiority margin of 250 mL.
The investigators also looked at secondary outcomes related to escalation of postpartum hemorrhage care, such as whether additional interventions were needed.
Key Findings
From October 2020 through May 2023, 64 participants were randomized. The average blood loss at the time the balloon was inserted was 2,133 mL, indicating that these were substantial hemorrhage cases. Thirty-one participants were assigned to the 18-hour group and 33 to the 6-hour group. Two participants were later excluded because of protocol violation.
The groups were similar at baseline, which supports a fair comparison. All participants received the assigned intervention, and intrauterine balloon tamponade successfully controlled bleeding in every randomized participant.
The main result was that blood loss remained low after balloon placement in both groups. The median blood loss 18 hours after balloon placement was:
– 135.0 mL in the 18-hour group
– 110.0 mL in the 6-hour group
This difference was statistically significant in favor of the 6-hour group, but the most important point is that the shorter duration was noninferior within the study’s predefined margin. In practical terms, 6 hours did not perform worse than 18 hours in a clinically meaningful way.
There were no differences in secondary outcomes between groups. No signal suggested that shorter balloon duration increased the need for extra procedures or worsened hemorrhage control.
What the Results Mean
The findings suggest that once postpartum bleeding from uterine atony has been controlled with intrauterine balloon tamponade, leaving the balloon in place for 6 hours may be enough for many patients after vaginal delivery.
This has several potential advantages. A shorter balloon duration could allow earlier postpartum mobility, reduce discomfort, and decrease the amount of time a patient needs close device-specific monitoring. It may also make bed management and nursing workflows easier in busy labor and delivery settings.
Importantly, the study does not mean that every patient can safely have the balloon removed at 6 hours. Clinical judgment still matters. Patients with ongoing bleeding, hemodynamic instability, coagulopathy, retained placenta, uterine infection, or other complications may need longer observation or additional treatment. The trial’s results apply best to patients whose hemorrhage has stabilized and who meet criteria for balloon tamponade as used in the study.
How Intrauterine Balloon Tamponade Works
Intrauterine balloon tamponade works by filling the uterine cavity with a balloon that exerts direct pressure on bleeding vessels in the uterine lining. This helps compress the site of bleeding and supports clot formation while the uterus continues to contract.
It is typically used after initial measures such as uterine massage and uterotonic medications. In some cases, it can prevent the need for more invasive interventions such as uterine artery embolization, surgical compression sutures, or hysterectomy. For this reason, balloon tamponade is an important step in obstetric hemorrhage management and an effective uterus-preserving option.
The question of timing is particularly relevant because once the uterus is contracting well and blood loss has slowed, the main reason to keep the balloon in place is to reduce the risk of rebleeding. This trial suggests that, at least in the setting studied, a shorter duration can provide that protection just as well as a longer one.
Clinical Practice Implications
If these results are incorporated into practice, hospitals may consider revising postpartum hemorrhage protocols to allow balloon removal after 6 hours in stable patients. That could streamline care and make management more patient-centered.
Potential benefits of a shorter duration include:
– Less discomfort and earlier return to movement
– Reduced time with an intrauterine device in place
– Simplified monitoring and nursing care
– Possibly shorter postpartum intervention time overall
That said, protocol changes should be thoughtful and local policies should reflect the characteristics of the patient population, staffing, and backup resources. Facilities may still choose longer balloon duration for high-risk patients or if their clinical pathways are built around extended observation.
A reasonable approach is to view 6 hours as an evidence-based option rather than a universal rule. The key is ensuring that bleeding is controlled, vital signs are stable, and the care team can monitor for recurrence.
Limitations to Keep in Mind
Like all clinical studies, this trial has limitations. The sample size was relatively small, which is common in randomized obstetric intervention studies but means the findings should be interpreted carefully. The trial was designed to detect noninferiority within a specific blood-loss margin, so results depend on that chosen threshold.
Also, the study focused on postpartum hemorrhage after vaginal delivery due to uterine atony. The findings may not directly apply to postpartum hemorrhage after cesarean delivery, hemorrhage caused by placental abnormalities, trauma, or clotting disorders, or cases where a balloon is used as part of a more complex escalation pathway.
Finally, while the trial showed excellent outcomes in both groups, real-world practice can vary. Differences in balloon type, insertion technique, concurrent medications, postpartum monitoring, and institutional experience may influence results.
Bottom Line
This randomized trial provides useful evidence that 6 hours of intrauterine balloon tamponade is noninferior to 18 hours for controlling blood loss after postpartum hemorrhage due to uterine atony following vaginal delivery.
For clinicians, the study supports the idea that balloon removal after 6 hours may be reasonable in stable patients whose bleeding has been controlled. For patients, it offers reassurance that a shorter duration may be just as effective, potentially with less discomfort and less time connected to the device.
Clinical trial registration: ClinicalTrials.gov NCT04467996.
